Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-20792 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD28 Monoclonal Antibody (CD28.2)
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- MA1-20792 detects CD28 in human and non-human primate samples.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- CD28.2
- Vial size
- 100 µg
- Concentration
- 0.5 mg/mL
- Storage
- 4° C, do not freeze
Submitted references CD161 contributes to prenatal immune suppression of IFNγ-producing PLZF+ T cells.
Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.
Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies.
Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.
Halkias J, Rackaityte E, Hillman SL, Aran D, Mendoza VF, Marshall LR, MacKenzie TC, Burt TD
The Journal of clinical investigation 2019 May 30;129(9):3562-3577
The Journal of clinical investigation 2019 May 30;129(9):3562-3577
Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
Wang Y, Ma CS, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, Payne K, Crestani E, Roncagalli R, Belkadi A, Kerner G, Lorenzo L, Deswarte C, Chrabieh M, Patin E, Vincent QB, Müller-Fleckenstein I, Fleckenstein B, Ailal F, Quintana-Murci L, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Puel A, Bustamante J, Boisson-Dupuis S, Malissen M, Malissen B, Abel L, Hovnanian A, Notarangelo LD, Jouanguy E, Tangye SG, Béziat V, Casanova JL
The Journal of experimental medicine 2016 Oct 17;213(11):2413-2435
The Journal of experimental medicine 2016 Oct 17;213(11):2413-2435
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.
Komdeur FL, Wouters MC, Workel HH, Tijans AM, Terwindt AL, Brunekreeft KL, Plat A, Klip HG, Eggink FA, Leffers N, Helfrich W, Samplonius DF, Bremer E, Wisman GB, Daemen T, Duiker EW, Hollema H, Nijman HW, de Bruyn M
Oncotarget 2016 Nov 15;7(46):75130-75144
Oncotarget 2016 Nov 15;7(46):75130-75144
Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies.
Cernea S, Herold KC
Clinical immunology (Orlando, Fla.) 2010 Feb;134(2):121-9
Clinical immunology (Orlando, Fla.) 2010 Feb;134(2):121-9
Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.
Macchia I, Gauduin MC, Kaur A, Johnson RP
Immunology 2006 Oct;119(2):232-42
Immunology 2006 Oct;119(2):232-42
No comments: Submit comment
No validations: Submit validation data